Back
Logitech International SA Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
49
LOGI
Logitech International SA
Last Price:
87.08
Seasonality Move:
13%
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.50
Seasonality Move:
5.7%
Sell
49
Logitech International SA (LOGI)
is a Sell
Is Logitech International SA a Buy, Sell or Hold?
- The current Logitech International SA [LOGI] share price is $85.66. The Score for LOGI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- LOGI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LOGI Stock Price Chart
What is Logitech International SA's stock price today?
-
The Logitech International SA share price today is $85.66
The current trend is relatively stagnant and LOGI is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $71.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
LOGI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.09 | Sell |
| Relative Strength Index (14 RSI): | 42.25 | Sell |
| Chaikin Money Flow: | -381502 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.66 - 91.1) | Sell |
| Bollinger Bands (100): | (85.11 - 96.45) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.61 | Sell |
| Relative Strength Index (14 RSI): | 22.64 | Sell |
| Chaikin Money Flow: | 871265 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (80.02 - 93.28) | Sell |
| Bollinger Bands (100): | (78.57 - 88.29) | Sell |
LOGI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.49 | Buy |
| 20-day SMA: | 87.94 | Sell |
| 50-day SMA: | 88.54 | Sell |
| 200-day SMA: | 89.75 | Sell |
| 8-day EMA: | 86.04 | Sell |
| 20-day EMA: | 87.06 | Sell |
| 50-day EMA: | 88.7 | Sell |
| 200-day EMA: | 86.89 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.35 | Sell |
| 20-day SMA: | 85.57 | Sell |
| 50-day SMA: | 85.93 | Sell |
| 200-day SMA: | 87.02 | Sell |
| 8-day EMA: | 77.71 | Sell |
| 20-day EMA: | 82.86 | Sell |
| 50-day EMA: | 84.86 | Sell |
| 200-day EMA: | 86.16 | Sell |
Logitech International SA Earnings Growth & LOGI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.77 per share, and an increase next year of $0.51 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Logitech International SA Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||